Meeder Asset Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Meeder Asset Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9	Closed	–	–	2684
2019 Q4	$0	Buy	+9	New	+$44	﹤0.01%	2562

Other funds holding CEMI

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Meeder Asset Management's CEMI Position: Q1 2020 in Review

Meeder Asset Management sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2020, closing a stake of 9 shares.

Meeder Asset Management first reported a position in CEMI in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 42 funds tracked by Wall St. Rank hold CEMI as of Q1 2020.

Meeder Asset Management reported no remaining Chembio diagnostics, Inc. position as of Q1 2020 after selling out during the quarter.
Meeder Asset Management sold 9 Chembio diagnostics, Inc. shares in Q1 2020.
Meeder Asset Management first reported a position in Chembio diagnostics, Inc. in Q4 2019 and held it in 1 quarter.
Meeder Asset Management's Chembio diagnostics, Inc. position peaked at $0 in Q4 2019.
42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.